Detecting and Managing Insulin Resistance
Harnessing Advances for Improving Exome
The Power of Pharmacogenomics in Clinical Practice
Give Us Your Feedback
Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia.
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening
Maternal iAMP21 Acute Lymphoblastic Leukemia Detected on Prenatal Cell-Free DNA Genetic Screening
Maternal Chromosome Xp Deletion Identified by Prenatal Cell-free DNA Screening.
Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS).
Improving the Accuracy of Prenatal Screening with DNA Copy-Number Analysis
Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD
Regions of homozygosity identified by oligonucleotide SNP arrays: evaluating the incidence and clinical utility.